Concert Pharmacueticals

Concert Pharmaceuticals completes enrollment in second open label trial of CTP-543 in alopecia areata
Pharmaceutical Business Review
Wed, 09/18/19 - 10:05 am
Concert Pharmacueticals
clinical trials
CTP-543
alopecia areata